Roche Holding AG turned once again to Jiangsu Hansoh Pharmaceutical Group Co. Ltd. to source novel antibody-drug conjugates ...

Guangzhou Patronus Biotech Co. Ltd. has obtained ethical approval in Australia from Bellberry Ltd. for a first-in-human phase I trial of three novel multi-stage virus-like-particle (VLP)-based ...

GSK plc won U.S. FDA clearance for bepirovirsen under the brand name Hibsago, marking the first antisense oligonucleotide (ASO) for chronic hepatitis B.

Australia must make biotechnology a strategic national industry and build on its clinical trial strengths as political pressure on U.S. scientific institutions and China’s rise reshape global drug ...

Visara Inc., a majority-owned ophthalmology subsidiary of Novabridge Biosciences Inc., has entered into an asset purchase option agreement with Yolo Immune Inc.

Saniona AB has submitted an IND application to the FDA for SAN-2465 for the treatment of major depressive disorder. Pending IND clearance, a phase I study in healthy volunteers is expected to begin by ...

At the recent 39th Annual Congress of the European Association of Nuclear Medicine, researchers from SK Biopharmaceuticals Co. Ltd. reported the preclinical activity of [225Ac]Ac-SKL-37171, a novel ...

Rxmp Therapeutics Inc. has been awarded up to $10.7 million from the U.S. Department of War through the Defense Advanced ...

New blood-based biomarker tests that detect Alzheimer’s before symptoms appear are poised to transform the clinical landscape by catching the disease when controlling for risk factors is known to have ...

At the United European Gastroenterology Week 2026 annual conference being held in Barcelona Oct. 17-20, a team of researchers from the Karolinska Institutet, the Sahlgrenska University Hospital and ...

Hitting statistical significance and proof of concept in phase II for bipolar mania, Rapport Therapeutics Inc. is moving to ...

Although a mediated settlement is already on the table awaiting court approval, the U.S. Court of Appeals for the Fifth Circuit breathed new life into Cassava Sciences Inc.’s fight to stave off a ...